Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Tenocyte Implantation for Chronic Achilles Tendinopathy
2010-021869-73Phase 3Completed
- Sponsor
- Orthocell
- Start
- Sep 2010
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of autologous tenocytes in Achilles tendinitis (AT) (2 arms), sponsored by Orthocell. Primary endpoint: Safety of autologous tenocyte implantation. Started Sep 2010; status: completed.
02
Drugs
autologous tenocytes
03
Conditions
Achilles tendinitis (AT)
Beyond the preview
Go deeper on 2010-021869-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021869-73.